TNP-ATP (triethylammonium)

TNP-ATP triethylammonium is a selective P2X receptor antagonist. TNP-ATP triethylammonium shows antinociceptive effects in rats[1].

Product Specifications

CAS Number

[61368-63-6]

UNSPSC

12352005

Target

P2X Receptor

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Applications

Neuroscience-Neuromodulation

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/tnp-atp-triethylammonium.html

Concentration

10 mM * 89.05 μL in Water

Purity

98.70

Solubility

10 mM in DMSO

Smiles

CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.NC1=NC=NC2=C1N=CN2[C@H](O3)[C@H](O4)[C@H](OC54C([N+]([O-])=O)=CC([N+]([O-])=O)=CC5[N+]([O-])=O)[C@H]3COP(O)(OP(OP(O)(O)=O)(O)=O)=O

Molecular Formula

C40H77N12O19P3

Molecular Weight

1123.03

References & Citations

[1]Jarvis MF, et al. Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X (3) allosteric modulator, cibacron blue. Br J Pharmacol. 2001 Jan;132 (1) :259-69.